Bookmark

Add to MyYahoo RSS

Bristol Myers Squibb News

News on Bristol Myers Squibb (Ticker: BMYPR) continually updated from thousands of sources around the net.

9 hrs ago | GuruFocus.com

Vanguard Health Care Fund's Top Second Quarter Stocks

Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.

Comment?

Related Topix: Financial Markets, Biotech, Merck , Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Bristol-Myers Squibb, Pharmaceuticals

14 hrs ago | The Daily Caller

Selena Gomez Shows Off Skin In Snakeskin Halter Top

The movie, which has the same producer as the 1999 classic "Ten Things I Hate About You," premieres Aug. 1. Meanwhile, Justin Bieber was getting swung on by Orlando Bloom .

Comment?

Related Topix: Charitable Organizations, American Cancer Society, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry

Tue Jul 29, 2014

Pharmaceutical Processing

European Commission Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Bristol-Myers Squibb and Pfizer announced that the European Commission has approved Eliquis for the treatment of DVT and PE, and the prevention of recurrent DVT and PE in adults.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Pfizer

Mon Jul 28, 2014

Pharmaceutical Technology

Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies

Bristol-Myers Squibb and Ono Pharmaceutical signed a collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea, and Taiwan.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Health, Lung Cancer

Fri Jul 25, 2014

Seeking Alpha

Why Bristol-Myers Squibb Loses Out Against This Rival

We pitch two companies from the GICS sector 'health care distributors and services', Bristol-Myers Squibb and Express Scripts, against one another in the latest instalment of our Head-To-Head series.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Social Solutions, Express Scripts, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Seeking Alpha

BioMed signs Bristol-Myers to more lab and office space

Bristol-Myers Squibb has signed a 10-year lease for about 61K square feet of additional lab and office space at BioMed Realty Trust's Woodside Technology Park in Redwood City, CA.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals, San Mateo County, CA, Redwood City, CA

Thu Jul 24, 2014

BioSpace

Bristol-Myers Squibb Company Appoints As India Country Head

Bristol-Myers Squibb India appointed Jitendra Tyagi as the BMS India country head.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals

Wed Jul 23, 2014

Customer Interaction Solutions

Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce...

Ono Pharmaceutical Co., Ltd. have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Health, Lung Cancer

The Motley Fool

Earnings Preview: Bristol-Myers Squibb and Celgene Corporation

Most health care stocks have been experiencing a roller coaster ride so far this year.

Comment?

Related Topix: Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals, Biotech, Celgene, Medicine, Healthcare Industry, Bristol Myers Squibb

Forbes.com

Forbes Earnings Preview: Bristol Myers Squibb

Bristol Myers Squibb reports its second-quarter earnings on Thursday, July 24, 2014, and the consensus earnings per share estimate is 45 cents per share.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Financial Markets

Thu Jul 17, 2014

Value Line

Drug Roundup - July 17, 2014

There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Merck , Eli Lilly, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Pharmaceuticals

Thu Jul 10, 2014

The Motley Fool

Top Biotech Stocks to Watch Today: Allergan, Arena Pharmaceuticals and Bristol-Myers Squibb

Let's take a look at today's top stories in biotech and health care. Keep an eye out for Allergan .

Comment?

Related Topix: Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals, Allergan, Biotech

Pharmaceutical Processing

Bristol-Myers Squibb Makes Plans to Submit Biologics License Application for OpdivoA

Bristol-Myers Squibb Company today announced that, following discussions with the U.S. Food and Drug Administration , the company is planning a third quarter submission of a Biologics Licensing Application for OpdivoA for previously treated advanced melanoma.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Law, Law

Tue Jul 08, 2014

AmericanBankingNews.com

Bristol-Myers Squibb Given New $55.00 Price Target at Leerink Swann

Leerink Swann's price objective would suggest a potential upside of 14.92% from the stock's previous close.

Comment?

Related Topix: Bristol Myers Squibb, Biotech, Medicine, Healthcare Industry, Bristol-Myers Squibb, Bloomsbury Publishing, Media, Publishing, Medarex, Pharmaceuticals

Mon Jul 07, 2014

Information Technology

Japan Approves First All-Oral, Interferon- and Ribavirin-Free...

Bristol-Myers Squibb Company announced today that the Japanese Ministry of Health, Labor and Welfare has approved Daklinza , a potent, pan-genotypic NS5A replication complex inhibitor , and Sunvepra , a NS3/4A protease inhibitor, providing a new treatment that can lead to cure for many patients in Japan who currently have no treatment options.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Hepatitis, Health, Bristol-Myers Squibb, Pharmaceuticals

Health Data Management

Duke, Bristol-Myers Squibb Open Up Study Data

These areas, it says, will refine ICD-10 plans to minimize impacts on productivity and reimbursement.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry

Sun Jul 06, 2014

The Motley Fool

1 State's Plan to Fight the AIDS Epidemic

The State of New York recently announced its bold plan to fight back against AIDS in a press release titled " Governor Cuomo Announces Plan to End the AIDS Epidemic in New York State ."

Comment?

Related Topix: HIV/AIDS, Health, Epidemic, Natural Disasters, Andrew Cuomo, US Governors, Control Group, Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Pharmaceuticals

Thu Jul 03, 2014

Seeking Alpha

Bristol-Myers Squibb May Be Fast-Tracking Its Promising Cancer Drug

However, with the recent release of promising data and the early termination of the first batch of Phase 3 trials, the drug may hit the market sooner than expected.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Oncology

Wed Jul 02, 2014

In-PharmaTechnologist.com

B-MS recalls CMO made injectable blood thinner after finding "visible particles"

Bristol Myers Squibb has recalled several batches of the injectable version of the blood thinner Coumadin made by its CMO, Pharmalucence.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Bedford, MA

Tue Jul 01, 2014

The Jersey Journal

Strong-smelling fertilizer spills in Hopewell Twp., closes roads for an hour

HOPEWELL TOWNSHIP - An unknown liquid with a strong odor spilled on Titus Mill Road and brought out emergency personnel from four agencies, forced the closure of the rear entrance to a business and for a short while closed an intersection, police said today.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••